Snakebite & Venomics
Addressing a neglected tropical disease through advanced proteomics and collaborative research to develop next-generation snakebite antivenoms.
A Silent Global Health Crisis
Snakebite envenoming is a major, yet often overlooked, public health issue, primarily affecting the most vulnerable populations in rural communities across Africa, Asia, and Latin America. Each year, it is estimated that up to 5.4 million people are bitten by snakes, leading to as many as 138,000 deaths and leaving 400,000 more with permanent physical disabilities and disfigurement.
The World Health Organization (WHO) has rightfully classified snakebite envenoming as a high-priority neglected tropical disease (NTD), launching a global strategy to halve its devastating impact by 2030.
The Power of Venomics
ResinTox, aim to leverage cutting-edge venomics—the comprehensive analysis of venom composition using proteomics and other novel ‘-omics’ technologies—to unravel the complexities of snake venoms. This deep understanding is the key to develop safer, more effective, and more affordable antivenoms.
Venom Characterization
We meticulously investigate the properties of the protein profiles of medically important snake venoms to identify the key toxins responsible for pathology.
Antivenom Assessment
Using innovative methods, we evaluate the effectiveness of existing antivenoms and identify gaps in their neutralizing capabilities.
Next-Gen Therapeutics
Our research paves the way for rationally designed, broad-spectrum antivenoms and small-molecule inhibitors to treat snakebites.
Join the Effort
Collaboration is at the heart of tackling this global challenge. Explore our research, learn about our network, and discover how ResinTox is contributing to the WHO’s 2030 goal.